Cronos Group Inc. has grown revenue 30% a year over three years and 26% a year over five. Revenue growth, 3-year annual rate: +30% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +26%, growth has picked up over the last three years. Years of annual history on file: 9, FY2017 to FY2025, as filed.

CRONCronos Group Inc.

Healthcare

$3.23+23% 1Y

$3.23

$2.3052 weeks$3.55

Is it growing?

Excellent

Growing: revenue growing +37% year on year, earnings up +233% year on year, and operating margin widening (+39.0 points).

3 good

Revenue trend+37% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +26% a year.

Earnings trend+233% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+39.0 points operating

Trailing-twelve-month operating margin, -2.1% now against -41.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CRON growing?

Cronos Group Inc. has grown revenue 30% a year over three years and 26% a year over five.

+30%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +26%
Revenue growth, 5-year rate · +30% over three · growth has picked up over the last three years
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›